Smoke Generator
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Autoimmune Drugs Market Research Report 2024
1 Autoimmune Drugs Market Overview
1.1 Product Overview and Scope of Autoimmune Drugs
1.2 Autoimmune Drugs Segment by Type
1.2.1 Global Autoimmune Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Rheumatoid Arthritis (RA)
1.2.3 Multiple Sclerosis (MS)
1.2.4 Psoriasis
1.2.5 Inflammatory Bowel Disease (IBD)
1.2.6 Ankylosing Spondylitis (AS)
1.2.7 Systemic Lupus Erythematosus (SLE)
1.3 Autoimmune Drugs Segment by Application
1.3.1 Global Autoimmune Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.4 Global Autoimmune Drugs Market Size Estimates and Forecasts
1.4.1 Global Autoimmune Drugs Revenue 2017-2028
1.4.2 Global Autoimmune Drugs Sales 2017-2028
1.4.3 Autoimmune Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Autoimmune Drugs Market Competition by Manufacturers
2.1 Global Autoimmune Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Autoimmune Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Autoimmune Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Autoimmune Drugs Manufacturing Sites, Area Served, Product Type
2.5 Autoimmune Drugs Market Competitive Situation and Trends
2.5.1 Autoimmune Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Autoimmune Drugs Players Market Share by Revenue
2.5.3 Global Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Autoimmune Drugs Retrospective Market Scenario by Region
3.1 Global Autoimmune Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Autoimmune Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Autoimmune Drugs Market Facts & Figures by Country
3.3.1 North America Autoimmune Drugs Sales by Country
3.3.2 North America Autoimmune Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Autoimmune Drugs Market Facts & Figures by Country
3.4.1 Europe Autoimmune Drugs Sales by Country
3.4.2 Europe Autoimmune Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Autoimmune Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Autoimmune Drugs Sales by Region
3.5.2 Asia Pacific Autoimmune Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Autoimmune Drugs Market Facts & Figures by Country
3.6.1 Latin America Autoimmune Drugs Sales by Country
3.6.2 Latin America Autoimmune Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Autoimmune Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Autoimmune Drugs Sales by Country
3.7.2 Middle East and Africa Autoimmune Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Autoimmune Drugs Historic Market Analysis by Type
4.1 Global Autoimmune Drugs Sales Market Share by Type (2017-2022)
4.2 Global Autoimmune Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Autoimmune Drugs Price by Type (2017-2022)
5 Global Autoimmune Drugs Historic Market Analysis by Application
5.1 Global Autoimmune Drugs Sales Market Share by Application (2017-2022)
5.2 Global Autoimmune Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Autoimmune Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Autoimmune Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Eli Lilly Autoimmune Drugs Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Autoimmune Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 GSK Autoimmune Drugs Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Corporation Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Autoimmune Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 AbbVie Autoimmune Drugs Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Autoimmune Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Johnson & Johnson Autoimmune Drugs Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Biogen
6.5.1 Biogen Corporation Information
6.5.2 Biogen Description and Business Overview
6.5.3 Biogen Autoimmune Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Biogen Autoimmune Drugs Product Portfolio
6.5.5 Biogen Recent Developments/Updates
6.6 Amgen
6.6.1 Amgen Corporation Information
6.6.2 Amgen Description and Business Overview
6.6.3 Amgen Autoimmune Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Amgen Autoimmune Drugs Product Portfolio
6.6.5 Amgen Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Autoimmune Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Pfizer Autoimmune Drugs Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Roche
6.8.1 Roche Corporation Information
6.8.2 Roche Description and Business Overview
6.8.3 Roche Autoimmune Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Roche Autoimmune Drugs Product Portfolio
6.8.5 Roche Recent Developments/Updates
6.9 Baxter
6.9.1 Baxter Corporation Information
6.9.2 Baxter Description and Business Overview
6.9.3 Baxter Autoimmune Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Baxter Autoimmune Drugs Product Portfolio
6.9.5 Baxter Recent Developments/Updates
7 Autoimmune Drugs Manufacturing Cost Analysis
7.1 Autoimmune Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Autoimmune Drugs
7.4 Autoimmune Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Autoimmune Drugs Distributors List
8.3 Autoimmune Drugs Customers
9 Autoimmune Drugs Market Dynamics
9.1 Autoimmune Drugs Industry Trends
9.2 Autoimmune Drugs Market Drivers
9.3 Autoimmune Drugs Market Challenges
9.4 Autoimmune Drugs Market Restraints
10 Global Market Forecast
10.1 Autoimmune Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Autoimmune Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Autoimmune Drugs by Type (2023-2028)
10.2 Autoimmune Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Autoimmune Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Autoimmune Drugs by Application (2023-2028)
10.3 Autoimmune Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Autoimmune Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Autoimmune Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Autoimmune Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Autoimmune Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Autoimmune Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Autoimmune Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Autoimmune Drugs Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Autoimmune Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Autoimmune Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Autoimmune Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Autoimmune Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Autoimmune Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Autoimmune Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Autoimmune Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Autoimmune Drugs Sales by Region (2017-2022) & (K Units)
Table 16. Global Autoimmune Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Autoimmune Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Autoimmune Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Autoimmune Drugs Sales by Country (2017-2022) & (K Units)
Table 20. North America Autoimmune Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Autoimmune Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Autoimmune Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Autoimmune Drugs Sales by Country (2017-2022) & (K Units)
Table 24. Europe Autoimmune Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Autoimmune Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Autoimmune Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Autoimmune Drugs Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Autoimmune Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Autoimmune Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Autoimmune Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Autoimmune Drugs Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Autoimmune Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Autoimmune Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Autoimmune Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Autoimmune Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Autoimmune Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Autoimmune Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Autoimmune Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Autoimmune Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Global Autoimmune Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Autoimmune Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Autoimmune Drugs Revenue Share by Type (2017-2022)
Table 43. Global Autoimmune Drugs Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Autoimmune Drugs Sales (K Units) by Application (2017-2022)
Table 45. Global Autoimmune Drugs Sales Market Share by Application (2017-2022)
Table 46. Global Autoimmune Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Autoimmune Drugs Revenue Share by Application (2017-2022)
Table 48. Global Autoimmune Drugs Price by Application (2017-2022) & (USD/Unit)
Table 49. Eli Lilly Corporation Information
Table 50. Eli Lilly Description and Business Overview
Table 51. Eli Lilly Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Eli Lilly Autoimmune Drugs Product
Table 53. Eli Lilly Recent Developments/Updates
Table 54. GSK Corporation Information
Table 55. GSK Description and Business Overview
Table 56. GSK Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. GSK Autoimmune Drugs Product
Table 58. GSK Recent Developments/Updates
Table 59. AbbVie Corporation Information
Table 60. AbbVie Description and Business Overview
Table 61. AbbVie Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. AbbVie Autoimmune Drugs Product
Table 63. AbbVie Recent Developments/Updates
Table 64. Johnson & Johnson Corporation Information
Table 65. Johnson & Johnson Description and Business Overview
Table 66. Johnson & Johnson Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Johnson & Johnson Autoimmune Drugs Product
Table 68. Johnson & Johnson Recent Developments/Updates
Table 69. Biogen Corporation Information
Table 70. Biogen Description and Business Overview
Table 71. Biogen Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Biogen Autoimmune Drugs Product
Table 73. Biogen Recent Developments/Updates
Table 74. Amgen Corporation Information
Table 75. Amgen Description and Business Overview
Table 76. Amgen Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Amgen Autoimmune Drugs Product
Table 78. Amgen Recent Developments/Updates
Table 79. Pfizer Corporation Information
Table 80. Pfizer Description and Business Overview
Table 81. Pfizer Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Pfizer Autoimmune Drugs Product
Table 83. Pfizer Recent Developments/Updates
Table 84. Roche Corporation Information
Table 85. Roche Description and Business Overview
Table 86. Roche Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Roche Autoimmune Drugs Product
Table 88. Roche Recent Developments/Updates
Table 89. Baxter Corporation Information
Table 90. Baxter Description and Business Overview
Table 91. Baxter Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Baxter Autoimmune Drugs Product
Table 93. Baxter Recent Developments/Updates
Table 94. Production Base and Market Concentration Rate of Raw Material
Table 95. Key Suppliers of Raw Materials
Table 96. Autoimmune Drugs Distributors List
Table 97. Autoimmune Drugs Customers List
Table 98. Autoimmune Drugs Market Trends
Table 99. Autoimmune Drugs Market Drivers
Table 100. Autoimmune Drugs Market Challenges
Table 101. Autoimmune Drugs Market Restraints
Table 102. Global Autoimmune Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 103. Global Autoimmune Drugs Sales Market Share Forecast by Type (2023-2028)
Table 104. Global Autoimmune Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 105. Global Autoimmune Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 106. Global Autoimmune Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 107. Global Autoimmune Drugs Sales Market Share Forecast by Application (2023-2028)
Table 108. Global Autoimmune Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 109. Global Autoimmune Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 110. Global Autoimmune Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 111. Global Autoimmune Drugs Sales Market Share Forecast by Region (2023-2028)
Table 112. Global Autoimmune Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 113. Global Autoimmune Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Autoimmune Drugs
Figure 2. Global Autoimmune Drugs Market Share by Type in 2021 & 2028
Figure 3. Rheumatoid Arthritis (RA) Product Picture
Figure 4. Multiple Sclerosis (MS) Product Picture
Figure 5. Psoriasis Product Picture
Figure 6. Inflammatory Bowel Disease (IBD) Product Picture
Figure 7. Ankylosing Spondylitis (AS) Product Picture
Figure 8. Systemic Lupus Erythematosus (SLE) Product Picture
Figure 9. Global Autoimmune Drugs Market Share by Application in 2021 & 2028
Figure 10. Hospitals
Figure 11. Homecare
Figure 12. Specialty Clinics
Figure 13. Global Autoimmune Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Autoimmune Drugs Market Size (2017-2028) & (US$ Million)
Figure 15. Global Autoimmune Drugs Sales (2017-2028) & (K Units)
Figure 16. Autoimmune Drugs Sales Share by Manufacturers in 2021
Figure 17. Global Autoimmune Drugs Revenue Share by Manufacturers in 2021
Figure 18. The Global 5 and 10 Largest Autoimmune Drugs Players: Market Share by Revenue in 2021
Figure 19. Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Autoimmune Drugs Sales Market Share by Region (2017-2022)
Figure 21. Global Autoimmune Drugs Sales Market Share by Region in 2021
Figure 22. Global Autoimmune Drugs Revenue Market Share by Region (2017-2022)
Figure 23. Global Autoimmune Drugs Revenue Market Share by Region in 2021
Figure 24. U.S. Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Canada Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Germany Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. France Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. U.K. Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Italy Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Russia Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Japan Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. South Korea Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. India Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Australia Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Taiwan Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Indonesia Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Thailand Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Malaysia Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Philippines Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Vietnam Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Mexico Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Brazil Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Argentina Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Turkey Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Saudi Arabia Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. U.A.E Autoimmune Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Sales Market Share of Autoimmune Drugs by Type (2017-2022)
Figure 49. Manufacturing Cost Structure of Autoimmune Drugs
Figure 50. Manufacturing Process Analysis of Autoimmune Drugs
Figure 51. Autoimmune Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly GSK AbbVie Johnson & Johnson Biogen Amgen Pfizer Roche Baxter